{"id":501566,"date":"2020-08-11T12:22:01","date_gmt":"2020-08-11T12:22:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=501566"},"modified":"2020-08-11T12:22:01","modified_gmt":"2020-08-11T12:22:01","slug":"choroidal-neovascularization-market-analysis-market-size-epidemiology-leading-companies-drugs-and-competitive-analysis-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/choroidal-neovascularization-market-analysis-market-size-epidemiology-leading-companies-drugs-and-competitive-analysis-by-delveinsight_501566.html","title":{"rendered":"Choroidal Neovascularization Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight"},"content":{"rendered":"
\"Choroidal<\/a><\/p>\n
\n
“Choroidal Neovascularization – Market Insights, Epidemiology, and Market Forecast-2030”<\/div>\n<\/div>\n<\/div>\n

(Albany, US) DelveInsight has launched a new report on Choroidal Neovascularization Market Insights, Epidemiology and Market Forecast-2030.<\/a><\/strong><\/p>\n

 <\/p>\n

DelveInsight’s “Choroidal Neovascularization – Market Insights, Epidemiology, and Market Forecast-2030”<\/strong> report delivers an in-depth understanding of the Choroidal Neovascularization, historical and forecasted epidemiology as well as the Choroidal Neovascularization market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

 <\/p>\n

Some of the key facts of the Report:<\/strong><\/p>\n

    \n
  1. There was population burden of 41, 111 adults with myopic CNV in the United States in 2014.<\/li>\n
  2. As per the study conducted by Jeffrey R. Willis etal. (2014), the estimated diopter-adjusted incidence of myopic CNV was 0.017% (95% CI, 0.010–0.030 among adults in the United States aged 18 years and older in 2014.The estimated point prevalence of FTD is 15 – 22\/100,000, and the incidence is 2.7-4.1\/100,000.<\/li>\n
  3. The Incidence of CNV in individuals with pathologic myopia was reported to be 5.2%-11.3%, and was bilateral in approximately 15% of patients.<\/li>\n<\/ol>\n

     <\/p>\n

    Key benefits of the Report<\/strong><\/p>\n

    1. Choroidal Neovascularization market report covers a descriptive overview and comprehensive insight of the Choroidal Neovascularization epidemiology and Choroidal Neovascularization market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/p>\n

    2. Choroidal Neovascularization market report provides insights on the current and emerging therapies. <\/p>\n

    3. Choroidal Neovascularization market report offers a global historical and forecasted market covering drug outreach in 7 MM.<\/p>\n

    4. Choroidal Neovascularization market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Choroidal Neovascularization market.<\/p>\n

     <\/p>\n

    Request for Sample Pages: <\/strong>https:\/\/www.delveinsight.com\/sample-request\/choroidal-neovascularization-market<\/a><\/p>\n

     <\/p>\n

    “According to DelveInsight’s analysis, Females are affected more as compared to males, in the case of Choroidal Neovascularization.”<\/strong><\/p>\n

     <\/p>\n

    Choroidal neovascularization<\/a> (CNV)<\/strong> involves the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space. CNV is a major cause of visual loss. The symptoms of CNV include a distortion or waviness of central vision or a gray\/black\/void spot in the central vision.<\/p>\n

    Conditions That May Cause Choroidal Neovascularization: <\/strong><\/p>\n

    • Age-related macular degeneration is the most common disease causing CNV, but other diseases that “stress” the retina, causing it to produce excess VEGF, or disrupting the barrier between the retina and choroid, can also cause CNV.<\/p>\n

    • In patients with pathologic myopia (extreme nearsightedness), the eye is longer than normal, and this lengthening stretches and stresses the retina.<\/p>\n

    • Ocular histoplasmosis is a fungal infection that can cause CNV.<\/p>\n

    • Eye trauma and angioid streaks (small breaks in one of the retina’s layers) can break the barrier between the retina and choroid, resulting in CNV.<\/p>\n

    • Severe ocular inflammation, a condition called uveitis, can also cause CNV.<\/p>\n

    • The ophthalmologist can detect CNV using a combination of techniques. First, during the dilated eye exam, she\/he may see a blister of fluid or bleeding in the retina. Then, using specialized imaging called optical coherence tomography (OCT), a cross-section picture of the retina is obtained. This image can detect even small amounts of fluid that have leaked into the retina from CNV.<\/p>\n

     <\/p>\n

    Some of the key companies working on Choroidal Neovascularization are:<\/strong><\/p>\n